BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6383521)

  • 21. Effect of substance P on the 5,7-dihydroxytryptamine induced alteration of the postnatal development of central serotonin neurons.
    Jonsson G; Hallman H
    Med Biol; 1983 Apr; 61(2):105-12. PubMed ID: 6192293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine.
    Saller CF; Stricker EM
    Neuropharmacology; 1978 Jul; 17(7):499-506. PubMed ID: 692815
    [No Abstract]   [Full Text] [Related]  

  • 23. The amine-depleting effects of 5,7-dihydroxytryptamine (5,7-DHT) in C57BL/6 mice do not increase with age.
    Finnegan KT; DeLanney LE; Irwin I; Ricaurte GA; Langston JW
    Brain Res; 1989 Sep; 496(1-2):251-6. PubMed ID: 2804634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5,7-Dihydroxytryptamine modifies excitability of rat dorsal raphe serotonergic neurons in vitro.
    Segal M
    Neurosci Lett; 1986 Nov; 71(3):306-10. PubMed ID: 3796886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of selective destruction of serotonergic neurons in nucleus raphe magnus on morphine-induced antinociception.
    Mohrland JS; Gebhart GF
    Life Sci; 1980 Dec 22-29; 27(25-26):2627-32. PubMed ID: 7219034
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal administration of 5,6-DHT or 5,7-DHT reduces morphine and substance P-antinociceptive activity in the rat.
    Rodríguez FD; Rodríguez RE
    Neuropeptides; 1989; 13(2):139-46. PubMed ID: 2472573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual behavior in male rats after intracerebral injection of 5,7-dihydroxytryptamine.
    Larsson K; Fuxe K; Everitt BJ; Holmgren M; Södersten P
    Brain Res; 1978 Feb; 141(2):293-303. PubMed ID: 626904
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 30. Failure of spinal cord serotonin depletion to alter analgesia elicited from the periaqueductal gray.
    Johannessen JN; Watkins LR; Carlton SM; Mayer DJ
    Brain Res; 1982 Apr; 237(2):373-86. PubMed ID: 7083001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of somatostatin receptors in rat hippocampus by treatment with 5,7-dihydroxytryptamine.
    Muñoz-Acedo G; López-Sañudo S; Arilla E
    Neurosci Lett; 1992 Oct; 146(1):60-4. PubMed ID: 1361978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia.
    Chance WT; von Meyenfeldt M; Fischer JE
    Pharmacol Biochem Behav; 1983 Jan; 18(1):115-21. PubMed ID: 6187026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3H-5-hydroxytryptamine accumulation by rat brain synaptic vesicles in a membrane-impermeant medium, and selective reduction by 5,7-dihydroxytryptamine.
    Ruth JA; Cuizon JV; Park SH; Ullman EA; Wilson WR
    Life Sci; 1986 Mar; 38(13):1193-201. PubMed ID: 3959750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
    Pranzatelli MR; Huang YY; Dollison AM; Stanley M
    Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective neurotoxic lesions of descending serotonergic and noradrenergic pathways in the rat.
    Berge OG; Fasmer OB; Tveiten L; Hole K
    J Neurochem; 1985 Apr; 44(4):1156-61. PubMed ID: 3919157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic ACTH treatment: influence on 5-HT2 receptors and behavioral supersensitivity induced by 5,7-dihydroxytryptamine lesions.
    Pranzatelli MR; Eng B
    Peptides; 1989; 10(1):5-8. PubMed ID: 2546129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of depletion of brain 5-hydroxytryptamine by 5,7-dihydroxytryptamine on ethanol tolerance and dependence in the rat.
    Wood JM
    Psychopharmacology (Berl); 1980 Jan; 67(1):67-72. PubMed ID: 6768080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure to produce blood pressure changes following pharmacological or surgical depletion of brain serotonin in the spontaneously hypertensive rat.
    Browning RA; Bramlet DG; Myers JH; Bundman MC; Smith ML
    Clin Exp Hypertens (1978); 1981; 3(5):953-73. PubMed ID: 6456876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord.
    Brown LM; Smith DL; Williams GM; Smith DJ
    Neurosci Lett; 1989 Jul; 102(1):103-7. PubMed ID: 2779841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.